NCT03576144View on ClinicalTrials.gov

This Study in Healthy Men Tests How Different Doses of BI 1265162 Are Taken up in the Body and How Well They Are Tolerated.

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 11, 2018

Primary Completion Date

December 6, 2018

Study Completion Date

December 6, 2018

Conditions
Healthy
Interventions
DRUG

BI 1265162

Multiple rising inhaled doses

DRUG

Placebo

Multiple rising inhaled doses

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03576144 - This Study in Healthy Men Tests How Different Doses of BI 1265162 Are Taken up in the Body and How Well They Are Tolerated. | Biotech Hunter | Biotech Hunter